home / stock / rvph / rvph news

RVPH News and Press, Reviva Pharmaceuticals Holdings Inc. From 03/26/24

Stock Information
Company Name: Reviva Pharmaceuticals Holdings Inc.
Stock Symbol: RVPH
Market: NASDAQ
Website: revivapharma.com
Menu
RVPH RVPH Quote RVPH Short RVPH News RVPH Articles RVPH Message Board
Get RVPH Alerts

News, Short Squeeze, Breakout and More Instantly...
RVPH - VERI, CHEK and CZOO among mid-day movers

2024-03-26 12:55:48 ET More on Mid-day movers & stocks. Veritone: Not An AI Stock To Bank On Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Check-Cap jumps on Nobul AI business combination Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M...
RVPH - Reviva to Present RECOVER Phase 3 Clinical Trial Data for Brilaroxazine in Schizophrenia at the ASCPT 2024 Annual Meeting

CUPERTINO, Calif., March 26, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous sys...

RVPH - Reviva to Present at the UBS Virtual CNS Day

CUPERTINO, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous sys...

RVPH - Reviva to Present at the 36th Annual ROTH Conference

CUPERTINO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous sys...
RVPH - Reviva Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

CUPERTINO, Calif., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syst...

RVPH - Reviva to Host KOL Event to Discuss Topline Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia

CUPERTINO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous syste...

RVPH - Reviva Pharmaceuticals files for $200M mixed securities shelf

2024-02-02 16:43:29 ET More on Reviva Pharmaceuticals AbbVie – Cerevel M&A deal lifts Reviva, Karuna Reviva Pharma slips on $30M stock offering Read the full article on Seeking Alpha For further details see: Reviva Pharmaceuticals files for $20...
RVPH - Reviva Pharmaceuticals to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference

CUPERTINO, Calif., Jan. 25, 2024 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and ca...

RVPH - Brain Disease Cures: 3 Neuroscience Stocks Targeting Revolutionary Breakthroughs

2024-01-23 07:32:27 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Some of the worst and most deadly diseases affect our brains. In multiple sclerosis, the immune system “causes communication problems between your brain and the rest of your body,”...

RVPH - Reviva to Present at Webull LIVE! Healthcare Webinar on January 17

CUPERTINO, CA / ACCESSWIRE / January 10, 2024 / Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPH) ("Reviva" or the "Company"), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central nervous system (CNS), inflammatory and cardio...
Previous 10 Next 10